We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLDN icon
5451
Willdan Group
WLDN
$1.04B
$423K ﹤0.01%
11,898
+5,488
+86% +$207K
GOOD
5452
Gladstone Commercial Corp
GOOD
$605M
$422K ﹤0.01%
20,064
-67,271
-77% -$1.51M
EVLO
5453
CALL
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$422K ﹤0.01%
+3,000
New +$594K
SCPS
5454
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$422K ﹤0.01%
+101,654
New +$523K
TPST icon
5455
Tempest Therapeutics
TPST
$13.7M
$421K ﹤0.01%
+2,236
New +$435K
IIIN icon
5456
Insteel Industries
IIIN
$593M
$420K ﹤0.01%
11,042
+2,401
+28% +$88.5K
NMTC icon
5457
NeuroOne Medical Technologies
NMTC
$14.7M
$419K ﹤0.01%
+17,692
New +$508K
OPAD icon
5458
Offerpad Solutions
OPAD
$18.3M
$419K ﹤0.01%
320
-9,662
-97% -$14.8M
QNCX icon
5459
Quince Therapeutics
QNCX
$22.9M
$419K ﹤0.01%
+23
New +$366K
RAD
5460
PUT
DELISTED
Rite Aid Corporation
RAD
$419K ﹤0.01%
29,500
+6,700
+29% +$105K
CHEF icon
5461
Chefs' Warehouse
CHEF
$4.71B
$418K ﹤0.01%
12,820
+5,945
+86% +$174K
NEX
5462
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$418K ﹤0.01%
90,863
-671,256
-88% -$2.7M
AGYS icon
5463
Agilysys
AGYS
$2.97B
$417K ﹤0.01%
7,970
-29,953
-79% -$1.64M
SRSA
5464
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$416K ﹤0.01%
42,154
+4,063
+11% +$39.9K
FLYX.WS icon
5465
CALL
flyExclusive Inc Warrants
FLYX.WS
$415K ﹤0.01%
+702,500
New +$549K
NFBK
5466
DELISTED
Northfield Bancorp
NFBK
$415K ﹤0.01%
24,169
-8,636
-26% -$142K
TCBS icon
5467
Texas Community Bancshares
TCBS
$50.8M
$415K ﹤0.01%
+26,882
New +$418K
SHCRW
5468
CALL
DELISTED
Sharecare, Inc. Warrant
SHCRW
$415K ﹤0.01%
+208,333
New +$305K
FRD icon
5469
Friedman Industries
FRD
$240M
$414K ﹤0.01%
+34,797
New +$440K
NGD
5470
DELISTED
New Gold Inc
NGD
$414K ﹤0.01%
+390,782
New +$537K
TOL icon
5471
Toll Brothers
TOL
$13.6B
$414K ﹤0.01%
7,495
-45,735
-86% -$2.7M
AVTX icon
5472
Avalo Therapeutics
AVTX
$965M
$411K ﹤0.01%
65
-1
-2% -$8.11K
JOBY icon
5473
CALL
Joby Aviation
JOBY
$7.03B
$411K ﹤0.01%
182,590
-1
-0% -$10
PFBC icon
5474
Preferred Bank
PFBC
$1.24B
$411K ﹤0.01%
6,167
-24,467
-80% -$1.5M
HIPO.WS
5475
CALL
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$411K ﹤0.01%
+446,634
New +$470K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.